Finance
Results: 1477-1488 of 37165

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma

Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer

Skanska divests two office buildings in Copenhagen, Denmark, for DKK 1.0 billion, about SEK 1.5 billion






